AkzoNobel (AKZOY)
(Delayed Data from OTC)
$21.90 USD
+0.16 (0.74%)
Updated Sep 23, 2024 03:59 PM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
Price, Consensus and EPS Surprise
AKZOY 21.90 +0.16(0.74%)
Will AKZOY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AKZOY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AKZOY
Should Value Investors Buy AkzoNobel (AKZOY) Stock?
Why Fast-paced Mover AkzoNobel (AKZOY) Is a Great Choice for Value Investors
AKZOY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing AkzoNobel (AKZOY) Right Now?
AKZOY or AIQUY: Which Is the Better Value Stock Right Now?
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Other News for AKZOY
Akzo Nobel to cut around 2,000 jobs globally as part of cost-cutting measure, enhance efficiency
Kepler Capital Keeps Their Buy Rating on Akzo Nobel NV (0A00)
AkzoNobel price target lowered by EUR 2 at Morgan Stanley
Axalta's Self-Improvement Not Yet Fully Rewarded
Akzo Nobel NV (0A00) Gets a Buy from Kepler Capital